Pursuant to Regulation 30 of SEBI (Listing of Obligation and Disclosure Requirements) Regulation, 2015, Shukra Pharmaceuticals has informed that it enclosed newspaper publication of Draft Letter of Offer (DLOF) for 'Right Issue'.
The above information is a part of company’s filings submitted to BSE.